[ad_1]
Al Marsad Journal: The United States Food and Drug Administration seeks approval of Pfizer-Biontech’s Covid-19 vaccine, further accelerating the previous dose clearance schedule, according to people familiar with the agency’s plans which spoke to the New York Times.
According to Al-Arabiya, the organizers were working to complete the process by Friday, but the paperwork took a long time and the procedures between the agency and the company were completed, and both could be approved if some elements of the exam Need more time.
The move would make Pfizer the first coronavirus vaccine to move from emergency use authorization to full approval by the Food and Drug Administration.
Source link
